Birla Tisya records INR 250 crore booking value in pre-launch window

~ Premium residential development in the heart of Bengaluru, sells 200 units in 3 days ~

Bengaluru, January 19 2022: Birla Estates Pvt Ltd, the real estate arm of Century Textiles and Industries Limited (CTIL), has recorded a booking value of INR 250 Crore* during the pre-launch of Birla Tisya. The residential development is a joint venture between Birla Estates and Subadra Textile, spread across 4.75 acres, and has sold 200 units in 3 days. The property is in one of the most premium locations in Bengaluru, Rajajinagar.
Birla Estates Pvt Ltd, the real estate arm of Century Textiles and Industries Limited (CTIL) has registered a remarkable success at the launch if their new project ‘Birla Tisya’ in Bengaluru. The project has recorded outstanding sales of 200 units worth a Booking Value of approximately INR 250 Crore* within just 3 days of the launch. This 4.75-acre residential development, which is a joint venture between Birla Estates Pvt Ltd and Subadra Textile, is in one of the most premium locations in Bengaluru, Rajajinangar.
Set to be one of Bengaluru’s first green-rated township with the Platinum pre-certification by the Indian Green Building Council (IGBC), the premium project offers social and lifestyle infrastructure with excellent connectivity to the airport, railway, and metro stations.
Mr. KT Jithendran, CEO, Birla Estates said, “We are elated to receive such an overwhelming response from our discerning customers who have time and again believed in the prestigious legacy of the Birla Estates Group. A premium residential development, Birla Tisya offers thoughtfully landscaped boulevard, series of tranquil gardens sweeping panoramic views and state-of-the-art home automation features. Our aim is to provide our customers with an elevated living experience with our LifeDesignedTM philosophy.”
Mr. VS Rajagopal, Managing Director, Subadra Textile Private Limited said, “We are excited about the overwhelming response from customers for our joint venture project with Birla Estates. True to the name ‘Tisya’ which means auspicious, it has brought auspicious moments for us since we launched the project. We are confident it will also do the same for our valued customers. This residential development will bring in an amazing skyline and landscape to the neighborhood. It’s going to be a landmark address. The high-rise premium project offers holistic amenities including Zen pavilion, tennis court, swimming pool with jacuzzi seats, senior’s pocket with foot reflexology, herb & spice garden, fragrance garden, sculpture garden and much more. Keeping abreast with the most advanced technology, Birla Tisya provides an unparalleled experience in holistic living.”
Birla Estates forayed in Bengaluru with the launch of Birla Alokya at Whitefield, offering villa like luxury with the vibrancy of apartment neighborhoods. Birla Tisya will be the company’s second project in the IT city.

City Today News

9341997936

Havells Strengthens ‘Make in India’ Vision Showcases India’s most-advanced robotic and Industry 4.0 standard manufacturing plant

* New manufacturing facility inaugurated for Washing Machines with an annual production capacity of 3 lakh units at Ghiloth
* Aims to consolidate and strengthen its position in washing machine and AC market in India
* Industry 4.0 compliant technology, with high level of automation and robotic touch-points, providingsuperior product quality in the segment
* MES (Manufacturing Execution System) system installed to have seamless real-time monitoring of the entire production cycle, improve productivity, reduce loss-time & wastage

Ghiloth, December 23rd, 2021: Havells India Ltd, the leading ‘Fast Moving Electrical Goods (FMEG)’ company in the country, today announced its vision to bolster its ‘Make in India’ strategy by showcasing its industry-first‘ Industry 4.0’manufacturing plant for Lloyd ACs in Ghiloth, Rajasthan. Diversifying its manufacturing prowess further, the Company has now also entered Washing Machine (WM) production at the same location in Ghiloth where the AC plant is located.The Washing Machine plant was inaugurated today by Mr. Amitabh Kant,Chief Executive Officer, NITI Aayog. Spread over 50 acres at Ghiloth, the greenfield WM unit will significantly strengthen Lloyd’sWM production capacity with a targeted output of3 lakh units annually.
With the enhanced manufacturing capacity, Lloyd is poised to have ~20 models of WMs and 50 SKUs of ACs in 2022, aiming to bolsterits presence in the domestic consumer durables segment. Currently manufacturing washing machines, the facility is equipped to expand to over 5 lakh units annually. The manufacturing plant consists of best-in-class machinery from Japan, Korea and Italy and is equipped with cutting-edge technologically advanced10 Robotic machines and AGV’s (Automated Guided Vehicle) and a fully integrated material management system. The plant also has Management Execution System – MES from Dassault, France which helps in real time monitoring of processes thereby improving productivity and reducing loss-time & wastage.

On his visit at the most advanced robotic and Industry 4.0 compliant consumer durable manufacturing plant, Mr. Amitabh Kant, CEO, NITI Aayog said, “The state-of-the-art facility for manufacturing Lloyd AC & Washing Machinesat Ghiloth is a testimony of Havells’ commitment towards Government’s aim to build an Atmanirbhar Bharat. Their Industry 4.0 standard manufacturing facility, with real-time monitoring system (MES), showcases Havells’ ability to manufacture world-class products at globally competitive prices”.

Addressing the media, Mr. Anil Rai Gupta, CMD, Havells India Limited said, “I am very happy to showcase this first-of-it- kind most-advanced robotic AC plant in the country to you. With a capex of Rs.500cr, thisplant symbolises our vision for the future where we are committed to produce world-class, innovative products using globally-benchmarked manufacturing systems & practices. This ‘Industry 4.0 plant’ complements Government of India’s ‘Make in India vision’ and helps us make world-class ACs that are being exported to over 25 countries across the globe.”

Speaking at the occasion, Mr. Shashi Arora, CEO-Lloyd,said, “Currently we are amongst the best-known brands in the Consumer Durables industry, as our products are well-known for their superior performance, high energy efficiency and cutting-edge technology. The high automation and management systems at the Ghiloth AC plant will help us further optimise our cost structure, make more efficient products and cement our foot-hold in this market. Increasing urbanization, higher purchasing power and the rise of an expanding middle class have acted as key growth drivers in the consumer-durables industry, and we intend to ride this wave of burgeoning demand by offering our customers a wide-range of innovative world-class products under the Lloyd brand”

City Today News

9341997936

Dr Agarwal’s Eye Hospital launches its new hospital in Indiranagar & plans to invest ₹175 crore in Karnataka over the next two years

Bengaluru, December 11, 2021: India’s leading eyecare specialists, Dr. Agarwal’s Eye Hospital plans to invest over ₹ 175 crore in expanding its presence in Karnataka over the next two years. The hospital chain made this announcement at the inauguration of its super-speciality eye care center at Indiranagar in Bengaluru.

The new center is offering free consultations for patients who are 50 years or above till the month end. Karnatakas Honourable Minister for Health & Family Welfare and Medical Education, Dr K Sudhakar inaugurated the Indiranagar facility in the presence of Dr. Adil Agarwal, CEO, Dr. Agarwals Eye Hospital. Shri P C Mohan, MP Bangalore Central also attended the event.

In the next two years, Dr Agarwal’s will set up around 25 hospitals in Karnataka at an investment of ₹150 crore. In addition, the Group will set up more than 30 vision centers at an investment of ₹ 25 crore, taking its total investment in the state to ₹ 175 crore over a two year period.

Dr Adil Agarwal, CEO, Dr Agarwal’s Eye Hospital, is optimistic about the Group’s growth prospects in Karnataka. “Karnataka has been a revenue generator for the Group, contributing approximately ₹100 crore to our overall business. Currently, we have 15 centers in the state (11 in Bangalore and 4 outside Bangalore). In the next 36 months, with all the expansion that we have lined up, we expect the state to contribute to ₹ 200 crore to the Groups business. Karnataka is an important state for us and we are committed to expanding our presence here both in Bengaluru and outside the city, he said.

Inaugurating the new facility at Indiranagar, Honourable Minister for Health & Family Welfare and Medical Education, Dr K Sudhakar, said, I am happy to inaugurate the new center at Indiranagar, which I am sure will offer the best eye care service to people in East Bengaluru and beyond. Vision care can change lives and Dr. Agarwals has been changing lives one at a time. It is good to know that Dr. Agarwals is opening more clinics across the state. The hospital chain is doing exemplary work in the field of eye care and new centers across the state will help more people receive the best eye care, he said.

Dr. Agarwals newest center in Indiranagar will be a refractive hub for the hospital chain, which means that all refractive surgeries from all of Dr. Agarwals branches in Karnataka will be performed out of this center. The center is equipped with advanced technology and the latest equipment to provide comprehensive eyecare in a holistic manner. The hospital is housed in two floors, spread across approximately 5,000 sq ft. The center will provide patients with 360-degree comprehensive eyecare under one roof, offering services such as general ophthalmology, cataract services, laser cataract surgery, retina & cornea services, glaucoma & orbit, refractive surgery and paediatric ophthalmology.

With the inauguration of this center, Dr. Agarwals Eye Hospitals now has a total network presence of 102 hospitals spread across India and Africa. The Groups presence spans across 11 countries and over 10 states in India. Its facilities are staffed by a team of over 400 ophthalmologists and 4,000 employees.

Dr. Agarwals has treated over 12 million patients so far and offers not only quality eyecare, but also academic and research programs in ophthalmology and related fields. The chain has been on a growth spree across the country, with more than 60 units added to its network in the past five years alone with latest addition made in Vijayawada in December, 2021.

City Today News

9341997936

Manipal Global Education Services launches Manipal MedAce

A unique digital learning and assessment resource for undergraduate MBBS students in India

2nd December 2021, Bangalore : Manipal Global Education Services, a leading international provider of quality business and marketing solutions in higher education, launched Manipal MedAce, a first-of-its-kind digital learning and assessment resource for undergraduate MBBS students in India.

Manipal MedAce is a comprehensive and outcome-driven MBBS learning resource built on academic and learner research. The product is designed around the principles of e-learning and is seamlessly mapped to the medical curriculum. Its features include interactive, multimedia learning modules for core topics, short lecture capsules from top Indian medical faculty, case-based learning tools, knowledge checkpoints, and question banks for exam practice. Manipal MedAce enables undergraduate MBBS students to optimize campus learning by providing access to a comprehensive and well-curated learning resource on a single platform.

Manipal MedAce was unveiled in the presence of Mr. Ravi Panchanadan, Managing Director & CEO – Manipal Global Education Services (MaGE), Mr. Balasundaram Athreya, Chief Digital Officer, Manipal Global and Business Head, Manipal MedAce, and Dr. Pragna Rao, Academic Advisor, Manipal MedAce.

Dr. Ranjan Pai, Chairman of Manipal Education and Medical Group (MEMG), said. “I am delighted to announce the launch of Manipal MedAce. Over the years, the Manipal Group has pioneered several novel initiatives that have paved the way for progress around the world – empowering people and transforming lives. With Manipal MedAce, we are combining our passion for innovation with a desire to positively impact Healthcare Education. Having been a student of medicine myself, I have a first-hand understanding of the challenges an MBBS student is faced with and Manipal MedAce is our effort to create a learning powerhouse for medical students.”

Speaking at the launch, Mr. Ravi Panchanadan, Managing Director & CEO – Manipal Global Education Services (MaGE), commented, “Manipal MedAce is the outcome of extensive market research done by us on the need gap present in undergraduate MBBS learning today. While there are multiple providers of learning products in the UG and PG Prep space, there is evident whitespace for actual MBBS learning, which we hope to fill through our offering. Manipal MedAce brings together our rich heritage and expertise in medical education and a deep understanding of learners and their needs. Through Manipal MedAce, we endeavour to enrich lives of MBBS learners, setting them up for success.”

Mr. Balasundaram Athreya, Chief Digital Officer, Manipal Global Education Services (MaGE) & Business Head, Manipal MedAce, added, “The present-day MBBS learner’s needs are core to Manipal MedAce’s design and development. Our mission, therefore, is to offer a comprehensive digital resource that supplements MBBS learning. Essentially the product ensures better management of time between campus learning and self-paced revision. Significant investment has been made in adapting e-learning design principles to the content enabling SMART self-study. Presented on an easy to navigate, multi-device capable, and feature-rich platform, the user experience and interface make for stress-free learning. Furthermore, we will be continuously engaged with the students on their learning journey through our help-desk and learner support functions.”

Dr. Pragna Rao , Academic Advisor, Manipal MedAce, said, “Manipal MedAce is that student-friendly digital resource built to supplement the CBME curriculum. The resource explains basic concepts and clarifies doubts helping the student to revise efficiently. Manipal MedAce’s curated content includes clinical, practical, and dissection videos, quizzes, lecture capsules, diagrams, and infographics. Linker case videos unique to Manipal MedAce, allow first-year MBBS students to have early clinical exposure and apply Basic Sciences principles in a hospital setting. Assessments include case-based and image-based questions to perform well in-class tests and university exams. Overall outcomes for the student include achieving competencies and skillsets required for an Indian Medical Graduate.”

Dr. H Sudarshan Ballal, Chairman, Manipal Hospitals, said, “Today, there is an increasing need for digital learning tools that can provide clinical and practical exposure, right from the start of a medical student’s learning journey. Manipal has always been a leader in innovation and introduction of cutting edge technology in the field of medicine and healthcare. Manipal MedAce is a huge step in the right direction and an incredible means of supplementing campus education. I am confident that Manipal MedAce will help build a generation of competent and confident doctors for the future”

Manipal MedAce is live from today. To access a preview login on to http://www.manipalmedace.com

City Today News

9341997936

AMPATH launches its Pathology Laboratory in Bangalore

Bangalore, November 26, 2021: After setting up consecutive successful labs across various locations, AMPATH (American Institute of Pathology & Laboratory Sciences Pvt Ltd) is all set to launch in Bangalore. With state-of-the-art facilities and an efficiently skilled team that would offer patients superior, advanced, accurate and reliable services.

AMPATH offers a wide range of best-in-class diagnostic services with over 2450 tests from Clinical Biochemistry, Hematology, Clinical Pathology, Microbiology, Immuno Phenotyping, Serology, Immunology, Histopathology, Cytology, Immunohistochemistry, Molecular diagnosis, NGS, Cytogenesis and much more. These services help in diagnosis and detection of various diseases affecting different organs and part of the body that can be extremely vital.

The lab has collaborated with UPMC, one of the top ranked hospitals in the United States, which allows them to work with the world’s leading clinicians to help them ensure customers comprehensive services that reflect precision and accuracy in every test conducted. AMPATH is the only Indian lab that has the sole privilege of collaborating with such an esteemed and acclaimed global medical organization. It has seamlessly managed to keep par with international standards in testing procedures and quality protocols that have been developed under the expert guidance of UPMC.

Dr. Jagprag Singh Gujral, Group CEO, South Asia, CTSI, commented, “We are extremely delighted and pleased to announce the launch of our newest lab in Bangalore. Working in tandem with achieving our vision, we are proud to have expanded our presence in one of the leading markets and will now be able to serve the population of Bangalore with its automated and best in class, advanced test profile and quality standards. CTSI, through its network of 16 Cancer Hospitals in South Asia, American Oncology Institute (AOI), Multispecialty – Citizens Specialty Hospital and chain of specialty diagnostic laboratories- AMPATH is at the forefront of providing outcome focused healthcare services in South Asia. We strive to provide top-notch services, innovation and quality driven results in all our endeavors.”

Dr. Vijay Kumar Vemuri, Group Chief Operating Officer, CTSI, said, “It is with utmost pride that we share the announcement of the launch of our newest lab in Bangalore. In keeping with AMPATH’s standards, the lab has automated streamlined processes, qualified and talented clinical experts with access to top-class technological equipment and are relentlessly trained to follow procedures that deliver accuracy in every single test.”

Commenting on the launch, Dr. Mukesh Agrawal, Lab Director, said, “We are elated on opening a new lab and expanding our presence in the city of Bangalore where we will be offering various diagnostic services inclusive of microbiology and molecular testing. With high-tech equipment and a team of skilled professionals, we hope to continually and efficiently service our customers with quality and enhanced healthcare services.”
AMPATH striving closer to its mission of providing world class service and accurate diagnosis, has multiple projects underway to aid its expansion across various geographical locations in India. They aim to meet India’s constantly changing dynamics in the healthcare sector with consistency and efficiency.
Currently, AMPATH has 11 existing Labs, 1700+ clients & one upcoming Labs in India, with approx. 2450 tests and profiles conducted. It delivers a spectrum of advanced diagnostic services emphasizing quality, ethics, innovation, and best-in-class laboratory practices with reliable performance.

City Today News

9341997936